Contact Us: 01282 426380
KM Financial Solutions | Germany’s BioNTech lowers price for U.S. IPO amid market volatility
53180
post-template-default,single,single-post,postid-53180,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Germany’s BioNTech lowers price for U.S. IPO amid market volatility

08 Oct Germany’s BioNTech lowers price for U.S. IPO amid market volatility

Posted at 16:54h in News by
0 Likes
German biotechnology firm BioNTech SE
lowered the price range for its U.S. initial public
offering (IPO) on Wednesday and said it would sell fewer shares,
making it the latest company to struggle to debut in the stock
market.

No Comments

Sorry, the comment form is closed at this time.